Literature DB >> 19297568

An uncertain future for cardiovascular drug development?

Alan M Garber1.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19297568     DOI: 10.1056/NEJMp0808414

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Accelerating the pulse of cardiovascular R&D.

Authors:  Andrew Plump
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

2.  Cardiovascular therapeutic discovery.

Authors:  Burns C Blaxall; Anthony J Muslin
Journal:  J Cardiovasc Transl Res       Date:  2010-08-27       Impact factor: 4.132

Review 3.  Genome-wide association studies of late-onset cardiovascular disease.

Authors:  J Gustav Smith; Christopher Newton-Cheh
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

Review 4.  Advancing cardiovascular research.

Authors:  Michael S Lauer
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium.

Authors:  Therese Heinonen; David D Waters; Peter Libby; Jean-Claude Tardif
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

Review 6.  Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

7.  Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.

Authors:  Adie Viljoen; Anthony S Wierzbicki
Journal:  Drug Healthc Patient Saf       Date:  2010-05-24

8.  Insights from systems pharmacology into cardiovascular drug discovery and therapy.

Authors:  Peng Li; Yingxue Fu; Jinlong Ru; Chao Huang; Jiangfeng Du; Chunli Zheng; Xuetong Chen; Pidong Li; Aiping Lu; Ling Yang; Yonghua Wang
Journal:  BMC Syst Biol       Date:  2014-12-24

Review 9.  The current state of drug discovery and a potential role for NMR metabolomics.

Authors:  Robert Powers
Journal:  J Med Chem       Date:  2014-03-03       Impact factor: 7.446

Review 10.  Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012.

Authors:  Thomas J Hwang; Julie C Lauffenburger; Jessica M Franklin; Aaron S Kesselheim
Journal:  JACC Basic Transl Sci       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.